Create a controlled route from product question and material understanding to formulation comparison, analytical procedure development, stability hypotheses and a reviewable transfer package.
Status. Planned, subject to gates
A potential project environment for Indian and international teams that need a defined formulation or measurement decision before committing to larger development, specialist studies or manufacturing transfer.
Construction and systems plan
Zones below form an interactive planning model. They are not an approved layout, room data sheet, construction package or qualification plan.
Register materials, preserve identity and condition, and control issue to authorised work.
Run small, decision-led comparisons without fixing the building around one product class.
Develop measurement procedures against a stated analytical target profile and decision consequence.
Connect raw data, method knowledge, formulation rationale, unresolved risks and future receiving laboratory needs.
Containment, air strategy, finishes, extract, drainage, cleaning and waste cannot be designed responsibly around an undefined material scope.
Evidence gate. Representative product classes, quantities, safety data and prohibited activities are documented.
Analytical instruments, controlled storage and digital records require stable services and an agreed recovery response.
Evidence gate. Power quality, backup philosophy, water need, gases, heat rejection, fibre and maintenance response are evidenced for the candidate site.
The first internal capability should not duplicate specialist capacity that can be accessed credibly with better economics or expertise.
Evidence gate. Turnaround, quality scope, sample transfer, confidentiality, cost and contingency are tested with qualified providers.
Select a planning marker to inspect purpose, work, evidence output, infrastructure and the gate that must be passed before activation.
Bounded formulation automation
Dispense and mix defined small volume formulation matrices under human approved protocols.
Equipment architecture
System categories remain candidates for technical and commercial diligence. Selection follows intended use, repeat demand, competence, infrastructure, lifecycle support and evidence value.
| System | Intended use | Decision output | Infrastructure | Activation gates |
|---|---|---|---|---|
| Bounded formulation automationRobotic liquid handling platform | Dispense and mix defined small volume formulation matrices under human approved protocols.Automation would execute a bounded protocol. It would not select clinical candidates or release product without accountable human decisions. | Comparable candidate data and an auditable record of the executed design. |
|
|
| Separation scienceUltra performance liquid chromatography | Explore identity, assay, impurity, degradation or another defined analytical question where chromatographic separation is suitable.No procedure would be described as validated or suitable for release until its applicable protocol, evidence and authority existed. | A development procedure, performance evidence and limitations for the stated use. |
|
|
| High information analytical scienceLiquid chromatography mass spectrometry | Investigate mass-related identity, degradation or impurity questions when lower-complexity techniques cannot answer the decision.The system would be internalised only if utilisation and expertise justify it; specialist analysis may remain partner-led. | A characterised signal, an uncertainty statement and a decision on internal use or specialist transfer. |
|
|
| Dosage form performanceDissolution and product performance systems | Compare release or dissolution behaviour under a defined method and product question.An exploratory result would not demonstrate bioequivalence, clinical performance or regulatory acceptance. | A candidate comparison and a documented view of method sensitivity and limitations. |
|
|
| Material understandingSpectroscopy and solid-state characterisation systems | Examine identity, solid form, compatibility or physical change where the selected technique is fit for the question.Illustrative system categories are not an equipment procurement commitment or evidence of current ownership. | A material risk view and a decision on candidate, method or specialist work. |
|
|
Experiments and work packages
These are proposed programme patterns, not active experiments, client engagements or promised outcomes.
Question. Which composition and process variables materially affect the defined candidate decision?
Define target product profile
Select variables and ranges
Execute controlled comparisons
Review uncertainty and interactions
Evidence output. A reasoned shortlist, model limitations and explicit questions for further work.
Stop or transfer gate. Stop, narrow or transfer when material risk, sample demand, expertise or value cannot support another internal cycle.
Question. Can the proposed procedure distinguish the signal needed for a defined stability decision?
Define analytical target
Explore sample preparation and separation
Challenge selectivity
Assess stage-appropriate performance
Evidence output. A development method, performance evidence, known limitations and a future validation or transfer brief.
Stop or transfer gate. Do not call the procedure validated; transfer to a qualified laboratory when the required quality state exceeds the approved internal scope.
Question. Can a bounded robotic workflow improve reproducibility or learning rate for this specific formulation question?
Define human approved objective
Verify robot and instrument interfaces
Run a limited comparison
Review exceptions and data provenance
Evidence output. A feasibility result covering repeatability, material use, operator time, failure modes and decision value.
Stop or transfer gate. Automation does not advance if manual work is safer, clearer or economically stronger for the real demand.
People and authority
Roles describe the capability and decision authority the environment would need. They are not current appointments, vacancies or staffing commitments.
Defines candidate questions, experimental design, material controls and interpretation.
Translates intended use into procedure development, performance assessment and transfer knowledge.
Integrates bounded protocols, robot safety, instrument interfaces and exception handling.
Reviews provenance, completeness, deviations, version state and authorised evidence handoff.
Partner outcomes
A potential project environment for Indian and international teams that need a defined formulation or measurement decision before committing to larger development, specialist studies or manufacturing transfer.
A clearer formulation shortlist, analytical plan and future development package.
A governed route to test product translation questions while preserving academic and commercial rights.
A more complete formulation and analytical transfer brief with unresolved risks visible before receipt.
Sustainability by measurement
Future targets require a defined baseline, boundary, method, accountable owner and independently reviewable data. None is represented as achieved today.
| Metric | Measurement | Design response | Decision use |
|---|---|---|---|
| Material used per decision | Mass or volume of active material, excipients, standards and consumables per completed decision gate | Miniaturise screening where scientifically valid and compare robotic and manual routes using the same decision boundary. | Select workflows on evidence yield as well as speed and cost.Lower material use would be measured per defined workflow; it is not assumed from automation. |
| Solvent inventory and waste route | Solvent purchased, used, recovered where feasible and sent to each disposal route | Make solvent choice, segregation, storage, recovery feasibility and contractor evidence visible at project level. | Support method, equipment, ventilation, recovery and externalisation choices.No zero-waste or closed-loop solvent claim is made. |
| Energy per instrument run and controlled storage condition | Submetered electricity and heat rejection associated with defined workflows and critical storage | Right size systems, schedule noncritical loads and preserve resilient power only where evidence integrity requires it. | Compare utilisation, outsourcing and equipment ownership cases.A future measurement plan is not evidence of current carbon performance. |
Sovereign innovation contribution
These are potential contributions to India-based scientific, engineering and transfer capability. They are not claims of national designation, government backing, independence from global partners or delivered public impact.
Keep more candidate reasoning, method knowledge and transfer preparation within an India-based scientific team.
Create clearer handoffs between discovery, formulation, analytical development, stability and qualified manufacturing partners.
Develop roles that connect pharmaceutical science, robotics, instrumentation, quality and data stewardship.
Primary sources and published precedents inform this planning model. Their status, limits and relationship to VARUNÉ are stated beside every link.
Provides the international guideline architecture for pharmaceutical development, risk, quality systems, stability, analytical procedures and continuous manufacturing.
Reading boundary. A guideline citation informs design questions. It does not establish compliance, validation, authorisation or inspection readiness.
Open primary sourceProvides the statutory rules that must be read against the intended Indian operator, product and activity.
Reading boundary. The applicable licence and authority route would require specialist Indian regulatory advice. No licence or approval is represented.
Open primary sourceRecords regional activity across pharmaceutics, pharmaceutical analysis, biotechnology, regulatory affairs, pharmacoinformatics and process chemistry.
Reading boundary. Institutional presence does not establish a partnership, access route, workforce commitment or endorsement of VARUNÉ Labs.
Open primary sourceDemonstrates a bounded research workflow connecting digital formulation, robotic make and test, near-infrared measurement, automated tablet testing and optimisation.
Reading boundary. The reported workflow and performance belong to that study. They are not evidence of general autonomy, VARUNÉ performance or GMP operation.
Open primary sourceShows liquid handling and Bayesian optimisation applied to a defined formulation screening question.
Reading boundary. This is a bounded non-GMP research precedent. It does not prove universal productivity or an active VARUNÉ experiment.
Open primary sourceSupports solvent inventories, miniaturisation and assessment of recovery or disposal routes at laboratory and process level.
Reading boundary. It does not establish a zero-waste result or a preferred recovery route for an undefined future process.
Open primary source